富国银行上调安进目标价至325美元

Core Viewpoint - Wells Fargo raised the target price for Amgen from $300 to $325 while maintaining a "hold" rating [1] Group 1 - The new target price reflects a positive outlook on Amgen's performance [1] - The "hold" rating suggests that the company is expected to perform in line with market expectations [1]